Armistice Capital’s Acurx Pharmaceuticals ACXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $551K | Buy |
+53,927
| New | +$551K | 0.01% | 152 |
|
|
2023
Q4 | – | Sell |
-25,000
| Closed | -$750K | – | 293 |
|
|
2023
Q3 | $750K | Sell |
25,000
-34,100
| -58% | -$1.02M | 0.01% | 149 |
|
|
2023
Q2 | $3.13M | Buy |
59,100
+45,100
| +322% | +$2.39M | 0.05% | 127 |
|
|
2023
Q1 | $969K | Sell |
14,000
-30,000
| -68% | -$2.08M | 0.01% | 137 |
|
|
2022
Q4 | $3.5M | Sell |
44,000
-9,300
| -17% | -$740K | 0.06% | 107 |
|
|
2022
Q3 | $3.2M | Buy |
+53,300
| New | +$3.2M | 0.06% | 111 |
|